North America Cardiac Biomarkers Testing Market (2019-2025)
The North America Cardiac Biomarkers Testing Market would witness market growth of 10.7% CAGR during the forecast period (2019–2025).
Cardiac biomarkers are used when cardiac myocytes are damaged partially or completely, and measuring these biomarkers in serum or plasma is useful during the diagnosis of myocardial infarction. Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome, and cardiac troponin (especially troponin I) is particularly useful in the diagnosis of myocardial infection due to its superior specificity compared to other cardiac biomarkers. Individuals who note symptoms of myocardial infarction and elevated troponin I or troponin T, are now classified as non-ST-segment elevation MI (NSTEMI). North America is dominating the global market, which can be attributed to the rising demand for cardiac testing, higher CVD prevalence rate, and the growing awareness towards cardiac diagnostics solutions.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
Market Segmentation:
By Type
Cardiac biomarkers are used when cardiac myocytes are damaged partially or completely, and measuring these biomarkers in serum or plasma is useful during the diagnosis of myocardial infarction. Cardiac markers are used in the diagnosis and risk stratification of patients with chest pain and suspected acute coronary syndrome, and cardiac troponin (especially troponin I) is particularly useful in the diagnosis of myocardial infection due to its superior specificity compared to other cardiac biomarkers. Individuals who note symptoms of myocardial infarction and elevated troponin I or troponin T, are now classified as non-ST-segment elevation MI (NSTEMI). North America is dominating the global market, which can be attributed to the rising demand for cardiac testing, higher CVD prevalence rate, and the growing awareness towards cardiac diagnostics solutions.
Based on Type, the market is segmented into Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP and NT-proBNP), Ischemia Modified Albumin and Others. Based on Application, the market is segmented into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis and Others. Based on Location of Testing, the market is segmented into Point of Care Testing and Laboratory Testing. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trivitron Healthcare Pvt. Ltd., ABBOTT Laboratories, Siemens AG, Becton, Dickinson AND Company, Bio-Rad laboratories, Inc., Randox Laboratories Limited, Danaher Corporation, Thermo Fisher Scientific, Inc., Johnson and Johnson and Quidel Corporation.
Scope of the Study
Market Segmentation:
By Type
- Creatine Kinase (CK-MB)
- Troponins
- Myoglobin
- Natriuretic Peptides (BNP and NT-proBNP)
- Ischemia Modified Albumin
- Others
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- Point of Care Testing
- Laboratory Testing
- US
- Canada
- Mexico
- Rest of North America
- Trivitron Healthcare Pvt. Ltd.
- Abbott Laboratories
- Siemens AG
- Becton, Dickinson AND Company
- Bio-Rad Laboratories, Inc.
- Randox Laboratories Limited
- Danaher Corporation
- Thermo Fisher Scientific, Inc.
- Johnson and Johnson
- Quidel Corporation
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiac Biomarkers Testing Market, by Type
1.4.2 North America Cardiac Biomarkers Testing Market, by Application
1.4.3 North America Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 North America Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
CHAPTER 3. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE
3.1.1 North America Creatine Kinase (CK-MB) Market by Country
3.1.2 North America Troponins Market by Country
3.1.3 North America Myoglobin Market by Country
3.1.4 North America Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 North America Ischemia Modified Albumin Market by Country
3.1.6 North America Others Market by Country
CHAPTER 4. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION
4.1.1 North America Myocardial Infarction Market by Country
4.1.2 North America Congestive Heart Failure Market by Country
4.1.3 North America Acute Coronary Syndrome Market by Country
4.1.4 North America Atherosclerosis Market by Country
4.1.5 North America Others Market by Country
CHAPTER 5. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING
5.1.1 North America Point of Care Testing Market by Country
5.1.2 North America Laboratory Testing Market by Country
CHAPTER 6. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY
6.1 USA Cardiac Biomarkers Testing Market
6.1.1 USA Cardiac Biomarkers Testing Market by Type
6.1.2 USA Cardiac Biomarkers Testing Market by Application
6.1.3 USA Cardiac Biomarkers Testing Market by Location of Testing
6.2 Canada Cardiac Biomarkers Testing Market
6.2.1 Canada Cardiac Biomarkers Testing Market by Type
6.2.2 Canada Cardiac Biomarkers Testing Market by Application
6.2.3 Canada Cardiac Biomarkers Testing Market by Location of Testing
6.3 Mexico Cardiac Biomarkers Testing Market
6.3.1 Mexico Cardiac Biomarkers Testing Market by Type
6.3.2 Mexico Cardiac Biomarkers Testing Market by Application
6.3.3 Mexico Cardiac Biomarkers Testing Market by Location of Testing
6.4 Rest of North America Cardiac Biomarkers Testing Market
6.4.1 Rest of North America Cardiac Biomarkers Testing Market by Type
6.4.2 Rest of North America Cardiac Biomarkers Testing Market by Application
6.4.3 Rest of North America Cardiac Biomarkers Testing Market by Location of Testing
CHAPTER 7. COMPANY PROFILES
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cardiac Biomarkers Testing Market, by Type
1.4.2 North America Cardiac Biomarkers Testing Market, by Application
1.4.3 North America Cardiac Biomarkers Testing Market, by Location of Testing
1.4.4 North America Cardiac Biomarkers Testing Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraint
CHAPTER 3. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE
3.1.1 North America Creatine Kinase (CK-MB) Market by Country
3.1.2 North America Troponins Market by Country
3.1.3 North America Myoglobin Market by Country
3.1.4 North America Natriuretic Peptides (BNP and NT-proBNP) Market by Country
3.1.5 North America Ischemia Modified Albumin Market by Country
3.1.6 North America Others Market by Country
CHAPTER 4. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION
4.1.1 North America Myocardial Infarction Market by Country
4.1.2 North America Congestive Heart Failure Market by Country
4.1.3 North America Acute Coronary Syndrome Market by Country
4.1.4 North America Atherosclerosis Market by Country
4.1.5 North America Others Market by Country
CHAPTER 5. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING
5.1.1 North America Point of Care Testing Market by Country
5.1.2 North America Laboratory Testing Market by Country
CHAPTER 6. NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY
6.1 USA Cardiac Biomarkers Testing Market
6.1.1 USA Cardiac Biomarkers Testing Market by Type
6.1.2 USA Cardiac Biomarkers Testing Market by Application
6.1.3 USA Cardiac Biomarkers Testing Market by Location of Testing
6.2 Canada Cardiac Biomarkers Testing Market
6.2.1 Canada Cardiac Biomarkers Testing Market by Type
6.2.2 Canada Cardiac Biomarkers Testing Market by Application
6.2.3 Canada Cardiac Biomarkers Testing Market by Location of Testing
6.3 Mexico Cardiac Biomarkers Testing Market
6.3.1 Mexico Cardiac Biomarkers Testing Market by Type
6.3.2 Mexico Cardiac Biomarkers Testing Market by Application
6.3.3 Mexico Cardiac Biomarkers Testing Market by Location of Testing
6.4 Rest of North America Cardiac Biomarkers Testing Market
6.4.1 Rest of North America Cardiac Biomarkers Testing Market by Type
6.4.2 Rest of North America Cardiac Biomarkers Testing Market by Application
6.4.3 Rest of North America Cardiac Biomarkers Testing Market by Location of Testing
CHAPTER 7. COMPANY PROFILES
7.1 Trivitron Healthcare Pvt. Ltd.
7.1.1 Company Overview
7.1.2 Recent strategies and developments:
7.1.2.1 Collaborations, partnerships and agreements:
7.1.2.2 Expansion:
7.2 ABBOTT Laboratories
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Approvals:
7.2.2 SWOT Analysis
7.3 Siemens AG (Siemens Healthineers, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Collaborations, partnerships and agreements:
7.3.5.2 Product launches:
7.3.6 SWOT Analysis
7.4 Becton, Dickinson and Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 Bio-Rad laboratories, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and mergers:
7.6 Randox Laboratories Limited
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Collaborations, partnerships and agreements:
7.7 Danaher Corporation (Beckman Coulter, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Collaborations, partnerships and agreements:
7.7.5.2 Approvals:
7.7.6 SWOT Analysis
7.8 Thermo Fischer Scientific, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.8.6 SWOT Analysis
7.9 Johnson and Johnson
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental &Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Collaborations, partnerships and agreements:
7.9.5.2 Acquisition and mergers:
7.9.6 SWOT Analysis
7.1 Quidel Corporation
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Regional Analysis
7.10.4 Research & Development Expenses
LIST OF TABLES
TABLE 1 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 USA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 USA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 CANADA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 CANADA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 70 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 71 KEY INFORMATION – SIEMENS AG
TABLE 72 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 73 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 74 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 75 KEY INFORMATION – DANAHER CORPORATION
TABLE 76 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 77 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 78 KEY INFORMATION – QUIDEL CORPORATION
TABLE 1 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 3 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 4 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 5 NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 NORTH AMERICA CREATINE KINASE (CK-MB) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 NORTH AMERICA TROPONINS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 NORTH AMERICA MYOGLOBIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 NORTH AMERICA NATRIURETIC PEPTIDES (BNP AND NT-PROBNP) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 NORTH AMERICA ISCHEMIA MODIFIED ALBUMIN MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 16 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 17 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 18 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 19 NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 NORTH AMERICA MYOCARDIAL INFARCTION MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 NORTH AMERICA CONGESTIVE HEART FAILURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 24 NORTH AMERICA ACUTE CORONARY SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 25 NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 NORTH AMERICA ATHEROSCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 NORTH AMERICA OTHERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 30 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 31 NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 NORTH AMERICA POINT OF CARE TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 NORTH AMERICA LABORATORY TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 36 NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 37 USA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 38 USA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 39 USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 USA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 42 USA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 43 USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 44 USA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 45 CANADA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 46 CANADA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 47 CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 CANADA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 50 CANADA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 51 CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 52 CANADA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 53 MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 54 MEXICO CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 55 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 58 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 59 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 60 MEXICO CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 61 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2015 - 2018, USD MILLION
TABLE 62 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET, 2019 - 2025, USD MILLION
TABLE 63 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 66 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 67 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2015 - 2018, USD MILLION
TABLE 68 REST OF NORTH AMERICA CARDIAC BIOMARKERS TESTING MARKET BY LOCATION OF TESTING, 2019 - 2025, USD MILLION
TABLE 69 KEY INFORMATION – TRIVITRON HEALTHCARE PVT. LTD.
TABLE 70 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 71 KEY INFORMATION – SIEMENS AG
TABLE 72 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 73 KEY INFORMATION – BIO-RAD LABORATORIES, INC.
TABLE 74 KEY INFORMATION – RANDOX LABORATORIES LIMITED
TABLE 75 KEY INFORMATION – DANAHER CORPORATION
TABLE 76 KEY INFORMATION – THERMO FISHER SCIENTIFIC, INC.
TABLE 77 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 78 KEY INFORMATION – QUIDEL CORPORATION
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 SWOT ANALYSIS: ABBOTT LABORATORIES
FIG 4 SWOT ANALYSIS: SIEMENS AG
FIG 5 SWOT ANALYSIS: BECTON, DICKINSON AND COMPANY
FIG 6 SWOT ANALYSIS: DANAHER CORPORATION
FIG 7 SWOT ANALYSIS: THERMO FISHER SCIENTIFIC, INC.
FIG 8 SWOT ANALYSIS: JOHNSON & JOHNSON
